BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Prognosis
174 results:

  • 1. The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat Liver Resection.
    Gon H; Komatsu S; Omiya S; Kido M; Fukushima K; Urade T; Yoshida T; Arai K; Ishida J; Nanno Y; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
    Anticancer Res; 2024 May; 44(5):2031-2038. PubMed ID: 38677757
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Establishment and external validation of prognosis prediction nomogram for patients with distant metastatic intrahepatic cholangiocarcinoma: based on a large population.
    Yuan C; Zou S; Wang K; Hu Z
    BMC Cancer; 2024 Feb; 24(1):227. PubMed ID: 38365630
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Qualitative flow metabolic phenotype of pancreatic cancer. A new prognostic biomarker?
    Riviere D; Aarntzen E; van Geenen E; Chang D; de Geus-Oei LF; Brosens L; van Laarhoven K; Gotthardt M; Hermans J
    HPB (Oxford); 2024 Mar; 26(3):389-399. PubMed ID: 38114400
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Impact of Minimal Pelvic Fluid in Locally Advanced pancreatic cancer: A Multicenter Retrospective Study.
    Lee J; Park JS; Jeong S; Lee DH; Lim JH; Cho SG; Kwon CI; Hyun JJ; Choe JW; Cho JH; Jang SI
    Turk J Gastroenterol; 2023 Dec; 34(12):1249-1256. PubMed ID: 37860834
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical features and prognostic factors of spinal metastatic pancreatic cancer: A retrospective observational study.
    Yun JH; Cho PG; Kim KT; Shin DA; Kim KN; Kim SH; Noh SH
    Medicine (Baltimore); 2023 Jul; 102(28):e34264. PubMed ID: 37443474
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon cancer.
    Jeon J; Lee DB; Shin SJ; Han DH; Chang JS; Han YD; Kim H; Lim JS; Kim HS; Ahn JB
    Clin Colorectal Cancer; 2023 Sep; 22(3):307-317. PubMed ID: 37271592
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Analysis of surgical treatment of appendix neuroendocrine neoplasms-17 years of single-center experience.
    Zhang HW; Jiang Y; Huang ZY; Zhou XC
    World J Surg Oncol; 2023 May; 21(1):150. PubMed ID: 37194067
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Survival impact of pancreatic resection for metastases in the pancreas: A retrospective multi-center study.
    Kinoshita S; Yamashita YI; Kitano Y; Hayashi H; Sugimachi K; Nishizaki T; Fukuzawa K; Kajiyama K; Miyanari N; Yoshizumi T; Takamori H; Baba H
    Surg Oncol; 2023 Jun; 48():101942. PubMed ID: 37043926
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A novel combined carbohydrate antigen 19-9 and lymphocyte-to-monocyte ratio score can predict early recurrence of resectable pancreatic ductal adenocarcinoma.
    Yugawa K; Maeda T; Nagata S; Sakai A; Taketani K; Yamaguchi S; Konishi K; Hashimoto K
    Surg Today; 2023 Oct; 53(10):1199-1208. PubMed ID: 36943449
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer.
    Ceylan F; Guven DC; Taban H; Aktepe O; Sahin TK; Kilickap S; Turker A; Hamaloglu E; Karakoc D; Isik A; Akyol A; Yalcin S; Dizdar O
    Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102091. PubMed ID: 36738855
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study.
    Mo A; Zhang Q; Xia F; Huang Z; Peng S; Cao W; Mei H; Ren L; Su Y; Gao H; Chen W
    Cancer Med; 2023 Apr; 12(7):7734-7747. PubMed ID: 36540041
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long-standing diabetes mellitus increases concomitant pancreatic cancer risk in patients with intraductal papillary mucinous neoplasms.
    Yamaguchi A; Tazuma S; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Toyota N; Sudo T; Kuraoka K; Kohno H
    BMC Gastroenterol; 2022 Dec; 22(1):529. PubMed ID: 36539713
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical Course, Genetic, and Immunohistochemical Characterization of Solid Pseudopapillary Tumor of the Pancreas (Frantz Tumors) in a Brazilian Cohort.
    Tostes FT; de Carvalho PFDC; Araújo RLC; Ribeiro RC; Apodaca-Torrez FR; Lobo EJ; Gomes DBD; Callegaro-Filho D; Schvartsman G; Moura F; Schraibman V; Goldenberg A; de Lima FT; Segatelli V; Uson Junior PLS
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292694
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer.
    Bakker A; Slack JC; Palanisamy N; Carskadon S; Ghosh S; Khalifeh I; Bismar TA
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3721-3728. PubMed ID: 35982181
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Survival of cancer survivors with a new pancreatic cancer diagnosis.
    Pruitt SL; Tavakkoli A; Zhu H; Heitjan DF; Gerber DE; Singal AG; Halm EA; Beg MS; Maddineni B; Kansagra AJ; Murphy CC
    Cancer Med; 2023 Jan; 12(1):200-212. PubMed ID: 35674139
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Recurrence After Resection of pancreatic cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis?
    Zambirinis CP; Midya A; Chakraborty J; Chou JF; Zheng J; McIntyre CA; Koszalka MA; Wang T; Do RK; Balachandran VP; Drebin JA; Kingham TP; D'Angelica MI; Allen PJ; Gönen M; Simpson AL; Jarnagin WR
    Ann Surg Oncol; 2022 Aug; 29(8):4962-4974. PubMed ID: 35366706
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients.
    Choi Y; Kim N; Kim KW; Jo HH; Park J; Yoon H; Shin CM; Park YS; Lee DH; Oh HJ; Lee HS; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH
    World J Gastroenterol; 2022 Mar; 28(9):933-947. PubMed ID: 35317055
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with pancreatic cancer.
    Omiya K; Oba A; Inoue Y; Kobayashi K; Wu YHA; Ono Y; Sato T; Sasaki T; Ozaka M; Sasahira N; Ito H; Saiura A; Takahashi Y
    Ann Surg; 2023 Jun; 277(6):e1278-e1283. PubMed ID: 35081567
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. TATI, TAT-2, and CRP as Prognostic Factors in Colorectal cancer.
    Björkman K; Kaprio T; Beilmann-Lehtonen I; Stenman UH; Böckelman C; Haglund C
    Oncology; 2022; 100(1):22-30. PubMed ID: 34794144
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
    Kang JS; Choi YJ; Byun Y; Han Y; Kim JH; Lee JM; Sohn HJ; Kim H; Kwon W; Jang JY
    Br J Surg; 2021 Dec; 109(1):105-113. PubMed ID: 34718433
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.